Cian Healthcare Ltd - 542678 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation of Resignation of Whole time Director12-07-2022
12-07-2022
Cian Healthcare Ltd - 542678 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are hereby enclosing a copy of the Certificate received from Bigshare Services Private Limited, the Registrar and Share Transfer Agent of the Company for the Quarter ended 30th day of June, 2022.08-07-2022
Cian Healthcare Ltd - 542678 - Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities07-07-2022
Cian Healthcare Ltd - 542678 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this is to inform that the Board of Directors of the Company have appointed Mrs. Swati Maheshwari as an Additional Director (Non-Executive, Independent) of the Company pursuant to the provisions of the Companies Act, 2013 and SEBI Listing Regulations.31-05-2022
Cian Healthcare Ltd - 542678 - Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF CIAN HEALTHCARE LIMITED ("THE COMPANY") HELD ON MAY 30, 2022.
Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are pleased to submit the Audited Financials Results for the Half year/Year ended 31st March, 2022 which was also approved by the Board of Directors of the Company at their meeting held on Monday, 30th May, 2022 at 5:00 P.M. and concluded at 6:55 P.M.30-05-2022
Cian Healthcare Ltd - 542678 - Submission Of Audited Financials Results For The Half Year/Year Ended On 31St March, 2022
Submission Of Audited Financials Results For The Half Year/Year Ended On 31St March, 202230-05-2022
Cian Healthcare Ltd - 542678 - Board Meeting Intimation for Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31St, 2022
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve In terms of the Regulation 29(1) (a) of the SEBI (LODR) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 30th May, 2022, inter-alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31st, 2022.25-05-2022
Cian Healthcare Ltd - 542678 - In Compliance Under Regulation 40(9) & (10) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Regarding Submission Of The Certificate Of Compliance Report Issued By DSM & ASSOCIATES, Company Secretaries For The Year Ended On 31St March, 2022.
In Compliance Under Regulation 40(9) & (10) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 regarding submission of the Certificate of Compliance Report issued by DSM & ASSOCIATES, Company Secretaries for the Year ended on 31st March, 2022.30-04-2022
Cian Healthcare Ltd - 542678 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2022.
Submission of Compliance Certificate under Regulation 7(3) of the SEBI (LODR) Regulations, 2015 for the Half Year/Year ended on 31st March, 2022.22-04-2022
Cian Healthcare Ltd - 542678 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MUNJAJI DHUMALDesignation :- Company Secretary and Compliance Officer20-04-2022